GSE135352 0 V 1 NAPABUCASIN HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE135352 0 V 1 NAPABUCASIN HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE135352 0 V 1 NAPABUCASIN HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE135352 0 V 1 NAPABUCASIN HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE135352 0 V 1 NAPABUCASIN HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

acetylserotonin O-methyltransferase like

Gene

valyl-tRNA synthetase 1

Gene

A-kinase anchoring protein 17A

Gene

uncharaterized LOC112694756

Gene

mitochondrial elongation factor 1 upstream open reading frame

Gene

thymosin beta 15C

Gene

mitochondrial rRNA methyltransferase 3

Gene

PHD finger protein 12

Gene

Jrk helix-turn-helix protein

Gene

solute carrier family 25 member 25

  • Gene

    acetylserotonin O-methyltransferase like


  • Gene

    valyl-tRNA synthetase 1


  • Gene

    A-kinase anchoring protein 17A


  • Gene

    uncharaterized LOC112694756


  • Gene

    mitochondrial elongation factor 1 upstream open reading frame


  • Gene

    thymosin beta 15C


  • Gene

    mitochondrial rRNA methyltransferase 3


  • Gene

    PHD finger protein 12


  • Gene

    Jrk helix-turn-helix protein


  • Gene

    solute carrier family 25 member 25

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.